.

Tuesday, January 21, 2014

Jubilant Life Valuation

Jubilant Life Sciences- Share impairment Valuation Submitted to: Prof. Sony Thomas, IIMK Submitted By: Alok Sinha (Roll #: ePGP-03-095) mesa of Content Jubilant Life Sciences- Share Price Valuation1 turn off of Content2 Business Verticals3 Valuation3 Order Book3 Earning calculate3 Financials3 Ratios4 Risks4 Recommendation: Buy, Undervalued4 References:4 Business Verticals Pharmaceutical telephone circuit contributes 52% to tax revenue o Generic condescension contributes 12 % -products in US and sensitive medicines like Methylpredisone, Lamo trigine and Meclizine o Specialty argumentation contributes 8% Ingredients business contributes 48% Valuation Based on the analysis of last 5 years the revenue CAGR is death to 13%, hence stand that revenue would be operation at the same govern in near future- assign for 5 years and thenceforth at a enjoin of 5%.
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
The net income is growing at around 16% per annum. At CMP of 158 the stock is duty at 9 measure its earning, which is significantly lower compared to its peers in same sector- other complete players in the same application have a P/E of 22. Order Book o Company s outstanding forward contracts for FY13 sta! nds at $278 M at the rank of Rs 53.72 o Radio pharmaceutical business unit win USD 5 M order which includes a tender from a hospital Earning Forecast The company is expected to earn Rs 324 crore in year 2013. The next quarter earnings should be in the vicinity of Rs 75 crore. Financials |  |CAGR |2012E |2013E |2014E |2015E |2016E | |Net Income...If you want to get a full essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper

No comments:

Post a Comment